Glaucoma is a leading cause of blindness worldwide, affecting over 60 million people. Traditional drug therapies for glaucoma such as prostaglandin analogues, beta blockers, and alpha agonists have been mainstays of treatment for decades. However, researchers continue working to develop new drugs with improved safety and tolerability profiles. A growing number of fixed-dose combination medications now allow for simultaneous treatment of multiple ... Read more
